Latest 10-K annual reports

Prime Medicine reported significant losses and expressed substantial doubt about its ability to continue as a going concern, despite advancing its gene editing pipeline and securing new collaborations.

OFS Capital Corporation's 2025 annual report reveals a significant decrease in net asset value per share and net losses on its investment portfolio, alongside strategic debt refinancing.

Scholar Rock's lead SMA drug, apitegromab, faces regulatory delays due to third-party manufacturing issues, while the company secures new financing and advances its pipeline.

Passage Bio reports continued operating losses in its 2025 annual filing, advancing its lead gene therapy candidate PBFT02 for neurodegenerative diseases while navigating financial and operational challenges.

Amylyx Pharmaceuticals reports a strategic shift following the withdrawal of its ALS drug, focusing on a pipeline of novel therapies for endocrine and neurodegenerative diseases, supported by significant capital raises.

Amarin Corporation plc reports a 7% decrease in total revenue for 2025, driven by declining U.S. VASCEPA sales amidst generic competition, while advancing international commercialization and restructuring efforts.

CECO Environmental Corp. reported a significant increase in net sales and operating income for 2025, driven by strategic acquisitions and strong demand in environmental solutions, while also announcing a major merger with Thermon Group Holdings, Inc.

Fluor Corporation filed an amendment to its 2025 Annual Report on Form 10-K to incorporate the consolidated financial statements of its equity investee, NuScale Power Corporation.

The abrdn Silver ETF Trust reported a 149% increase in silver spot price and a 282% rise in Net Asset Value for the fiscal year ended December 31, 2025, driven by strong industrial demand and investor interest.

The abrdn Precious Metals Basket ETF Trust reported a significant 147.84% increase in Net Asset Value for the fiscal year ended December 31, 2025, driven by strong Bullion price appreciation and increased outstanding shares.

The abrdn Palladium ETF Trust reported a significant increase in Net Asset Value and palladium price in 2025, driven by supply constraints and waning EV subsidies.

abrdn Platinum ETF Trust reported a significant 180.97% increase in Net Asset Value for the fiscal year ended December 31, 2025, driven by a 122.02% surge in platinum prices and increased outstanding shares.

abrdn Gold ETF Trust reported a significant 95.22% increase in Net Asset Value for 2025, driven by a 65% rise in gold prices and increased share creations.

Lincoln Educational Services Corporation reported a 17.8% revenue increase to $518.2 million and a 102.2% rise in net income for fiscal year 2025, driven by student population growth and strategic expansions.

Hestia Insight Inc. announced a strategic pivot to AI-powered advisory services, alongside a significant drop in annual revenue and a substantial net loss, raising going concern doubts.

Turning Point Brands, Inc. announced a significant increase in total net sales and gross profit for 2025, primarily fueled by robust growth in its modern oral products segment, despite a decline in Zig-Zag product sales.

Popular, Inc. announced a significant increase in net income and expanded net interest margin for 2025, driven by strategic transformation initiatives and loan growth.

RadNet's 2025 annual report reveals significant revenue growth driven by imaging center expansion and AI investments, alongside executive compensation increases and a net loss for common stockholders.

Calavo Growers, Inc. filed an amendment to its annual report to include previously omitted corporate governance and executive compensation details, citing a pending acquisition by Mission Produce, Inc.

Skyward Specialty Insurance Group, Inc. reported significant growth in 2025, driven by strong underwriting results and strategic expansion, including the acquisition of Apollo Group Holdings Limited.

Archer Aviation reports significant progress in eVTOL aircraft certification, expands its operational footprint with the acquisition of Hawthorne Airport, and continues substantial R&D investments despite increasing net losses.

Surgery Partners, Inc. reported a significant reduction in net loss and growth in revenue and Adjusted EBITDA for the fiscal year ended December 31, 2025, driven by same-facility performance and strategic acquisitions.

Alpha Teknova, a leading producer of critical reagents, announced a 7.4% revenue increase to $40.5 million and significantly narrowed its net loss to $17.3 million in its 2025 annual report.

Great Elm Capital Corp.'s 2025 annual report reveals a significant net asset decrease driven by unrealized depreciation and realized losses, despite growth in investment income.

Quantum Computing Inc. reported an 83% increase in total revenue for 2025, driven by product sales and strategic acquisitions, while continuing to incur significant operating losses and addressing internal control weaknesses.

Commerce.com, Inc. reported a reduced net loss of $19.3 million for fiscal year 2025, driven by strategic rebranding and increased investment in AI-driven commerce solutions, while remediating a material weakness in internal controls.

Riot Platforms, Inc. reported a net loss of $663.2 million in 2025 despite increased Bitcoin mining revenue, as it strategically expands into large-scale data center solutions for AI/HPC.

Cerus Corporation saw product and government contract revenue increase in 2025, leading to a reduction in net loss, despite ongoing regulatory challenges for its red blood cell system and significant debt obligations.

Ouster, Inc. reported a 52% increase in total revenue to $169.4 million for fiscal year 2025, driven by sensor sales and IP licensing royalties, alongside strategic acquisitions and a reduced net loss.

Kayne Anderson BDC, Inc. (KBDC) reported a decrease in net investment income and net assets for 2025, despite an increase in total investment income, reflecting market volatility and strategic portfolio adjustments.